Back to search

Prostate-specific membrane antigen (PSMA)-specific monoclonal antibodies in the treatment of prostate and other cancers.

Data up to Jan 2025

Published1999
Citations72
References36

Total Citations Per Year

Abstract

References (36)

Prostate-specific membrane antigen expression in normal and malignant human tissues.

1997 • 1,454 citations

Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.

1999 • 777 citations

Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma

1998 • 638 citations

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

1996 • 613 citations

Expression of the prostate-specific membrane antigen.

1994 • 582 citations

Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases

1998 • 563 citations

Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues

1995 • 541 citations

Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen.

1993 • 510 citations

Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium.

1997 • 509 citations

Prostate-specific membrane antigen is produced in tumor-associated neovasculature.

1999 • 438 citations

Constitutive and antibody-induced internalization of prostate-specific membrane antigen.

1998 • 419 citations

Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.

1996 • 380 citations

Detection and characterization of the prostate‐specific membrane antigen (PSMA) in tissue extracts and body fluids

1995 • 362 citations

Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase.

1996 • 360 citations

Enzyme nomenclature — Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology

1994 • 291 citations

Enzyme Nomenclature. Recommendations 1992

1994 • 247 citations

Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays.

1994 • 241 citations

Cancer Patient T Cells Genetically Targeted to Prostate-Specific Membrane Antigen Specifically Lyse Prostate Cancer Cells and Release Cytokines in Response to Prostate-Specific Membrane Antigen

1999 • 229 citations

Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization.

1997 • 210 citations

Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene

1998 • 190 citations

( 111 ) INDIUM-CAPROMAB PENDETIDE IN THE EVALUATION OF PATIENTS WITH RESIDUAL OR RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY

1998 • 177 citations

Radioimmunoscintigraphy with111Indium Labeled Cyt-356 for the Detection of Occult Prostate Cancer Recurrence

1994 • 148 citations

ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patients.

1998 • 111 citations

Biochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate-specific membrane antigen

1995 • 104 citations

Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell line.

1998 • 97 citations

Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase).

1998 • 88 citations

Indium-111 Capromab Pendetide (ProstaScint) Imaging to Detect Recurrent and Metastatic Prostate Cancer

1998 • 88 citations

Prostate-specific membrane antigen: evidence for the existence of a second related human gene

1995 • 88 citations

The T-body approach: potential for cancer immunotherapy

1996 • 87 citations

ISOLATION AND CHARACTERIZATION OF MONOCLONAL ANTIBODIES SPECIFIC FOR THE EXTRACELLULAR DOMAIN OF PROSTATE SPECIFIC MEMBRANE ANTIGEN

1998 • 62 citations

Recommended Name: Aminopeptidase B

1997 • 55 citations

Localization and Physical Mapping of the Prostate-Specific Membrane Antigen (PSM) Gene to Human Chromosome 11

1995 • 51 citations

Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.

1997 • 42 citations

Detection of Prostatic Specific Membrane Antigen Messenger RNA Using Immunobead Reverse Transcriptase Polymerase Chain Reaction

1999 • 38 citations

Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues

2000 • 31 citations

( 111 ) INDIUM-CAPROMAB PENDETIDE UNEXPECTEDLY LOCALIZES TO RENAL CELL CARCINOMA

1999 • 25 citations

Cited By (0)

Loading...
Prostate-specific membrane antigen (PSMA)-specific monoclonal antibodies in the treatment… (1999) – Cancer and Metastasis Reviews | Metascience Observatory Explorer